Chapter
The Slow Progression of Psychedelic Legalization
1:36:54 - 1:45:24 (08:30)
Despite the potential for therapeutic benefits, progress towards the legalization of psychedelic drugs has been slow. However, there have been recent developments with the passing of drug decriminalization in Oregon and compassionate access to psilocybin in Canada.
Clips
MAPS Public Benefit is currently leading research on the therapeutic benefits of MDMA and other psychedelics, with hopes of gaining FDA approval for doctors to prescribe them to patients with certain ailments in the near future.
1:36:54 - 1:40:33 (03:38)
Summary
MAPS Public Benefit is currently leading research on the therapeutic benefits of MDMA and other psychedelics, with hopes of gaining FDA approval for doctors to prescribe them to patients with certain ailments in the near future. It's unclear exactly when this will happen, but expanded access programs may allow patients to pay for the treatment themselves in the meantime.
ChapterThe Slow Progression of Psychedelic Legalization
Episode#202 – Rick Doblin: Psychedelics
PodcastLex Fridman Podcast
The USA needs a decade of rollouts of psychedelic clinics across the country that could transform people's minds on how patients should be treated with controlled substances.
1:40:33 - 1:45:24 (04:51)
Summary
The USA needs a decade of rollouts of psychedelic clinics across the country that could transform people's minds on how patients should be treated with controlled substances.